Repositório Científico do Instituto Nacional de Saúde >
Departamento de Genética Humana >
DGH - Posters/abstracts em congressos nacionais >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10400.18/652

Título: Refining the molecular characterization of calpainopathy (LGMD2A) patients
Autor: Maia, Nuno
Vieira, Emília
Santos, Rosário
Oliveira, Márcia E.
Palavras-chave: Doenças Genéticas
CAPN3 gene
Calpainopatia
Calpaína 3
Distrofia Muscular das cinturas
Protein analysis
Functional tests
Issue Date: Nov-2011
Editora: Sociedade Portuguesa de Genética Humana
Citação: 15ª Reunião Anual da SPGH : Livro de Resumos, 2011
Resumo: Introduction: Mutations in the gene CAPN3 are responsible for calpainopathy or limb-girdle muscular dystrophy type 2A (LGMD2A), one of the most frequent forms of LGMD. The gene CAPN3 codes for calpain-3 (or CAPN3), a muscle-specific calcium-dependent protease functionally regulated via its autolytic activity. Most of the patients show differences in CAPN3 abundance in muscle samples as compared to control muscles, by immunoblot analysis. Interestingly, a smaller group of patients with normal protein abundance presents abnormal CAPN3 autolytic function. We intend to complement the molecular studies already carried out on small group of Portuguese LGMD2A patients in order to establish genotype/phenotype correlations. Materials and methods: Muscle biopsy samples of 9 LGMD2A patients diagnosed in our laboratory were subjected to protein analysis and functional tests by western blotting and densitometry analyses. Additionally, gene expression studies were performed using real-time quantitative PCR. Results and discussion: The autolytic CAPN3 biochemical test was used in the patients that presented “normal” CAPN3 abundance in muscle biopsies (3 out of 9). The data obtained suggested that two of these patients had lost CAPN3 autolytic activity. Although, only one mutated allele had been found in one of these 2 patients after molecular genetic testing, this biochemical test was important in providing a differential diagnosis of LGMD2A in these patients. Real-time quantitative PCR was done in order to quantify differences in the expression level of the CAPN3 gene between patients’ samples and controls. Interestingly, no reduction of CAPN3 expression was observed in the samples tested (= 5). Additionally, two of them presented an overexpression of CAPN3 gene as compared to controls. Once again, in these 2 patients only one mutated allele had been detected. In these cases, the data suggests that the diagnosis of calpainopathy may be excluded in these 2 patients.
URI: http://hdl.handle.net/10400.18/652
Appears in Collections:DGH - Posters/abstracts em congressos nacionais

Files in This Item:

File Description SizeFormat
SPGH_Nuno.pdf.pdf306,49 kBAdobe PDFView/Open
Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

  © 2010 www.insa.pt - Todos os direitos reservados | Feedback Ministério da Saúde
Promotores do RCAAP   Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência PO Sociedade do Conhecimento (POSC) Portal oficial da União Europeia